Mark Garzotto

Professor

  • 3746 Citations
  • 31 h-Index
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial

Zhang, Z., Garzotto, M., Davis, E. W., Mori, M., Stoller, W. A., Farris, P. E., Wong, C. P., Beaver, L. M., Thomas, G. V., Williams, D. E., Dashwood, R. H., Hendrix, D. A., Ho, E. & Shannon, J., Jan 2 2020, In : Nutrition and Cancer. 72, 1, p. 74-87 14 p.

Research output: Contribution to journalArticle

2019

Dairy product consumption and prostate cancer risk in the United States

Preble, I., Zhang, Z., Kopp, R., Garzotto, M., Bobe, G., Shannon, J. & Takata, Y., Jul 2019, In : Nutrients. 11, 7, 1615.

Research output: Contribution to journalArticle

Open Access

Effect of chemotherapy with docetaxel with androgen suppression and radiotherapy for localized high-risk prostate cancer: The randomized phase III NRG Oncology RTOG 0521 Trial

Rosenthal, S. A., Hu, C., Sartor, O., Gomella, L. G., Amin, M. B., Purdy, J., Michalski, J. M., Garzotto, M. G., Pervez, N., Balogh, A. G., Rodrigues, G. B., Souhami, L., Reaume, M. N., Williams, S. G., Hannan, R., Horwitz, E. M., Raben, A., Peters, C. A., Feng, F. Y., Shipley, W. U. & 1 others, Sandler, H. M., Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1159-1168 10 p.

Research output: Contribution to journalArticle

25 Scopus citations

Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph Nodes

Chakiryan, N., Martinez, A., Gao, L., Liu, J-J., Amling, C., Garzotto, M. & Kopp, R., Jul 1 2019, In : The Journal of urology. 202, 1, p. 76-82 7 p.

Research output: Contribution to journalArticle

4 Scopus citations

Polymorphisms in oxidative stress pathway genes and prostate cancer risk

Zhang, Z., Jiang, D., Wang, C., Garzotto, M., Kopp, R., Wilmot, B., Thuillier, P., Dang, A., Palma, A., Farris, P. E. & Shannon, J., Dec 1 2019, In : Cancer Causes and Control. 30, 12, p. 1365-1375 11 p.

Research output: Contribution to journalArticle

1 Scopus citations
2018

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

Lara, P. N., Plets, M., Tangen, C., Gertz, E., Vogelzang, N. J., Hussain, M., Twardowski, P. W., Garzotto, M., Monk, J. P., Carducci, M., Goldkorn, A., Mack, P. C., Thompson, I., Van Loan, M. & Quinn, D. I., Jan 1 2018, In : Cancer Treatment and Research Communications. 16, p. 18-23 6 p.

Research output: Contribution to journalArticle

Endorectal MR imaging of prostate cancer: Evaluation of tumor capsular contact length as a sign of extracapsular extension

Mendez, G., Foster, B. R., Li, X., Shannon, J., Garzotto, M., Amling, C. L. & Coakley, F. V., Jul 1 2018, In : Clinical Imaging. 50, p. 280-285 6 p.

Research output: Contribution to journalArticle

2 Scopus citations
3 Scopus citations
2017

Cyclooxygenase-2 (COX-2) inhibition for prostate cancer chemoprevention: double-blind randomised study of pre-prostatectomy celecoxib or placebo

Flamiatos, J. F., Beer, T. M., Graff, J. N., Eilers, K. M., Tian, W., Sekhon, H. S. & Garzotto, M., May 1 2017, In : BJU international. 119, 5, p. 709-716 8 p.

Research output: Contribution to journalArticle

13 Scopus citations

Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlates

Bergstrom, C. P., Ruffell, B., Ho, C. M. T., Higano, C. S., Ellis, W. J., Garzotto, M., Beer, T. M. & Graff, J. N., Jan 2017, In : Anti-Cancer Drugs. 28, 1, p. 120-126 7 p.

Research output: Contribution to journalArticle

9 Scopus citations

Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421

Sonpavde, G., Pond, G. R., Plets, M., Tangen, C. M., Hussain, M. H. A., Lara, P. N., Goldkorn, A., Garzotto, M. G., Mack, P. C., Higano, C. S., Vogelzang, N. J., Thompson, I. M., Twardowski, P. W., Van Veldhuizen, P. J., Agarwal, N., Carducci, M. A., Monk, J. P. & Quinn, D. I., Dec 2017, In : Clinical Genitourinary Cancer. 15, 6, p. 635-641 7 p.

Research output: Contribution to journalArticle

2 Scopus citations
2016

Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial

Zhang, Z., Garzotto, M., Beer, T. M., Thuillier, P., Lieberman, S., Mori, M., Stoller, W. A., Farris, P. E. & Shannon, J., Nov 16 2016, In : Nutrition and Cancer. 68, 8, p. 1309-1319 11 p.

Research output: Contribution to journalArticle

4 Scopus citations

Gene-expression profiling of localized prostate cancer: Still miles to go before we sleep

Garzotto, M. & Kopp, R., Feb 1 2016, In : Future Oncology. 12, 3, p. 273-276 4 p.

Research output: Contribution to journalArticle

19 Scopus citations
2015

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial

Goldkorn, A., Ely, B., Tangen, C. M., Tai, Y. C., Xu, T., Li, H., Twardowski, P., Van Veldhuizen, P. J., Agarwal, N., Carducci, M. A., Monk, J. P., Garzotto, M., Mack, P. C., Lara, P., Higano, C. S., Hussain, M., Vogelzang, N. J., Thompson, I. M., Cote, R. J. & Quinn, D. I., Apr 15 2015, In : International Journal of Cancer. 136, 8, p. 1856-1862 7 p.

Research output: Contribution to journalArticle

23 Scopus citations
2014

Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomes

Gordon, R. R., Wu, M., Huang, C. Y., Harris, W. P., Sim, H. G., Lucas, J. M., Coleman, I., Higano, C. S., Gulati, R., True, L. D., Vessella, R., Lange, P. H., Garzotto, M., Beer, T. M. & Nelson, P. S., Sep 8 2014, In : PloS one. 9, 9, e104271.

Research output: Contribution to journalArticle

13 Scopus citations

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: A phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer

Goldkorn, A., Ely, B., Quinn, D. I., Tangen, C. M., Fink, L. M., Xu, T., Twardowski, P., Van Veldhuizen, P. J., Agarwal, N., Carducci, M. A., Monk, J. P., Datar, R. H., Garzotto, M., Mack, P. C., Lara, P., Higano, C. S., Hussain, M., Thompson, I. M., Cote, R. J. & Vogelzang, N. J., Apr 10 2014, In : Journal of Clinical Oncology. 32, 11, p. 1136-1142 7 p.

Research output: Contribution to journalArticle

179 Scopus citations

Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer

Barnett, C. M., Heinrich, M. C., Lim, J., Nelson, D., Beadling, C., Warrick, A., Neff, T., Higano, C. S., Garzotto, M., Qian, D., Corless, C. L., Thomas, G. V. & Beer, T. M., Jan 1 2014, In : Clinical Cancer Research. 20, 5, p. 1306-1312 7 p.

Research output: Contribution to journalArticle

12 Scopus citations
2013

Agent Orange as a risk factor for high-grade prostate cancer

Ansbaugh, N., Shannon, J., Mori, M., Farris, P. E. & Garzotto, M., Jul 1 2013, In : Cancer. 119, 13, p. 2399-2404 6 p.

Research output: Contribution to journalArticle

24 Scopus citations

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): A randomised phase 3 trial

Quinn, D. I., Tangen, C. M., Hussain, M., Lara, P. N., Goldkorn, A., Moinpour, C. M., Garzotto, M. G., Mack, P. C., Carducci, M. A., Monk, J. P., Twardowski, P. W., Van Veldhuizen, P. J., Agarwal, N., Higano, C. S., Vogelzang, N. J. & Thompson, I. M., Aug 1 2013, In : The Lancet Oncology. 14, 9, p. 893-900 8 p.

Research output: Contribution to journalArticle

120 Scopus citations

Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection

Li, X., Priest, R. A., Woodward, W. J., Tagge, I. J., Siddiqui, F., Huang, W., Rooney, W. D., Beer, T. M., Garzotto, M. G. & Springer, C. S., Jan 1 2013, In : Magnetic Resonance in Medicine. 69, 1, p. 171-178 8 p.

Research output: Contribution to journalArticle

24 Scopus citations
2012

Benign Prostatic Hyperplasia: A Brief Overview of Pathogenesis, Diagnosis, and Therapy

Priest, R., Garzotto, M. & Kaufman, J., Dec 1 2012, In : Techniques in Vascular and Interventional Radiology. 15, 4, p. 261-264 4 p.

Research output: Contribution to journalArticle

21 Scopus citations

Cell membrane water exchange effects in prostate DCE-MRI

Li, X., Priest, R. A., Woodward, W. J., Siddiqui, F., Beer, T. M., Garzotto, M. G., Rooney, W. D. & Springer, C. S., May 1 2012, In : Journal of Magnetic Resonance. 218, p. 77-85 9 p.

Research output: Contribution to journalArticle

18 Scopus citations
2011

Minimal benefit of an endorectal balloon for prostate immobilization as verified by daily localization

Hung, A. Y., Garzotto, M. & Kaurin, D., Jan 1 2011, In : Medical Dosimetry. 36, 2, p. 195-199 5 p.

Research output: Contribution to journalArticle

10 Scopus citations
2010

Acupuncture for hot flashes in patients with prostate cancer

Beer, T. M., Benavides, M., Emmons, S. L., Hayes, M., Liu, G., Garzotto, M., Donovan, D., Katovic, N., Reeder, C. & Eilers, K., Nov 1 2010, In : Urology. 76, 5, p. 1182-1188 7 p.

Research output: Contribution to journalArticle

32 Scopus citations

CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity

Qian, D. Z., Rademacher, B. L. S., Pittsenbarger, J., Huang, C. Y., Myrthue, A., Higano, C. S., Garzotto, M., Nelson, P. S. & Beer, T. M., Mar 1 2010, In : Prostate. 70, 4, p. 433-442 10 p.

Research output: Contribution to journalArticle

68 Scopus citations

Erythrocyte fatty acids and prostate cancer risk: A comparison of methods

Shannon, J., O'Malley, J., Mori, M., Garzotto, M., Palma, A. J. & King, I. B., Sep 1 2010, In : Prostaglandins Leukotrienes and Essential Fatty Acids. 83, 3, p. 161-169 9 p.

Research output: Contribution to journalArticle

20 Scopus citations

Histologic changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in patients with high-risk prostate cancer

O'Brien, C., True, L. D., Higano, C. S., Rademacher, B. L. S., Garzotto, M. & Beer, T. M., Apr 2010, In : American journal of clinical pathology. 133, 4, p. 654-661 8 p.

Research output: Contribution to journalArticle

34 Scopus citations

ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21

Geng, H., Rademacher, B. L., Pittsenbarger, J., Huang, C. Y., Harvey, C. T., Lafortune, M. C., Myrthue, A., Garzotto, M., Nelson, P. S., Beer, T. M. & Qian, D. Z., Apr 15 2010, In : Cancer Research. 70, 8, p. 3239-3248 10 p.

Research output: Contribution to journalArticle

27 Scopus citations

Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer

Garzotto, M., Higano, C. S., O'Brien, C., Rademacher, B. L. S., Janeba, N., Fazli, L., Lange, P. H., Lieberman, S. & Beer, T. M., Apr 1 2010, In : Cancer. 116, 7, p. 1699-1708 10 p.

Research output: Contribution to journalArticle

35 Scopus citations

Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer

Zhu, M. L., Horbinski, C. M., Garzotto, M., Qian, D. Z., Beer, T. M. & Kyprianou, N., Oct 15 2010, In : Cancer Research. 70, 20, p. 7992-8002 11 p.

Research output: Contribution to journalArticle

254 Scopus citations
2009

Folate intake and prostate cancer risk: A case-control study

Shannon, J., Phoutrides, E., Palma, A., Farris, P., Peters, L., Forester, A., Tillotson, C. J. & Garzotto, M., Sep 1 2009, In : Nutrition and Cancer. 61, 5, p. 617-628 12 p.

Research output: Contribution to journalArticle

30 Scopus citations

Lower urinary tract symptoms increase the risk of falls in older men

Parsons, J. K., Mougey, J., Lambert, L., Wilt, T. J., Fink, H. A., Garzotto, M., Barrett-Connor, E. & Marshall, L. M., Jul 1 2009, In : BJU international. 104, 1, p. 63-68 6 p.

Research output: Contribution to journalArticle

108 Scopus citations

Prostate cancer - Associated gene expression alterations determined from needle biopsies

Qian, D. Z., Huang, C. Y., O'Brien, C. A., Coleman, I. M., Garzotto, M., True, L. D., Higano, C. S., Vessella, R., Lange, P. H., Nelson, P. S. & Beer, T. M., May 1 2009, In : Clinical Cancer Research. 15, 9, p. 3135-3142 8 p.

Research output: Contribution to journalArticle

13 Scopus citations
2008

A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer

Chan, J. S., Beer, T. M., Quinn, D. I., Pinski, J. K., Garzotto, M., Sokoloff, M., Dehaze, D. R. & Ryan, C. W., Dec 1 2008, In : BJU international. 102, 11, p. 1601-1606 6 p.

Research output: Contribution to journalArticle

30 Scopus citations
2007

Assessment of Prostate-Specific Antigen Doubling Time in Prediction of Prostate Cancer on Needle Biopsy

Spurgeon, S. E. F., Mongoue-Tchokote, S., Collins, L., Priest, R., Hsieh, Y. C., Peters, L. M., Beer, T. M., Mori, M. & Garzotto, M., May 1 2007, In : Urology. 69, 5, p. 931-935 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Diethylstilbestrol and docetaxel: A phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer

Montgomery, R. B., Nelson, P. S., Lin, D., Ryan, C. W., Garzotto, M. & Beer, T. M., Sep 1 2007, In : Cancer. 110, 5, p. 996-1002 7 p.

Research output: Contribution to journalArticle

18 Scopus citations

Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: Identification of a cytoprotective mechanism involving growth differentiation factor 15

Huang, C. Y., Beer, T. M., Higano, C. S., True, L. D., Vessella, R., Lange, P. H., Garzotto, M. & Nelson, P. S., Oct 1 2007, In : Clinical Cancer Research. 13, 19, p. 5825-5833 9 p.

Research output: Contribution to journalArticle

52 Scopus citations

Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer

Beer, T. M., Javle, M. M., Ryan, C. W., Garzotto, M., Lam, G. N., Wong, A., Henner, W. D., Johnson, C. S. & Trump, D. L., Apr 1 2007, In : Cancer Chemotherapy and Pharmacology. 59, 5, p. 581-587 7 p.

Research output: Contribution to journalArticle

38 Scopus citations
16 Scopus citations
2006

Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsy

Spurgeon, S. E. F., Hsieh, Y. C., Rivadinera, A., Beer, T. M., Mori, M. & Garzotto, M., Mar 1 2006, In : Journal of Urology. 175, 3, p. 918-922 5 p.

Research output: Contribution to journalArticle

13 Scopus citations

Effect of calcitriol on prostate-specific antigen in vitro and in humans

Beer, T. M., Garzotto, M., Park, B., Mori, M., Myrthue, A., Janeba, N., Sauer, D. & Eilers, K., May 1 2006, In : Clinical Cancer Research. 12, 9, p. 2812-2816 5 p.

Research output: Contribution to journalArticle

13 Scopus citations

Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice

Zheng, X., Chang, R. L., Cui, X. X., Avila, G. E., Hebbar, V., Garzotto, M., Shih, W. J., Lin, Y., Lu, S. E., Rabson, A. B., Kong, A. N. T. & Conney, A. H., Jun 1 2006, In : Clinical Cancer Research. 12, 11 I, p. 3444-3451 8 p.

Research output: Contribution to journalArticle

21 Scopus citations

Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer

Purnell, J. Q., Bland, L. B., Garzotto, M., Lemmon, D., Wersinger, E. M., Ryan, C. W., Brunzell, J. D. & Beer, T. M., Feb 1 2006, In : Journal of lipid research. 47, 2, p. 349-355 7 p.

Research output: Contribution to journalArticle

19 Scopus citations

Metastatic adenocarcinoma of prostate in a healing sternotomy site

Adams, G., Mitchell, A., Ravichandran, R., Beer, T. M. & Garzotto, M., Jul 2006, In : Urology. 68, 1, p. 204.e13

Research output: Contribution to journalArticle

Testosterone loss and estradiol administration modify memory in men

Beer, T. M., Bland, L. B., Bussiere, J. R., Neiss, M. B., Wersinger, E. M., Garzotto, M., Ryan, C. W. & Janowsky, J. S., Jan 1 2006, In : Journal of Urology. 175, 1, p. 130-135 6 p.

Research output: Contribution to journalArticle

84 Scopus citations
2005

Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer

Janoff, D. M., Peterson, C., Mongoue-Tchokote, S., Peters, L., Beer, T. M., Wersinger, E. M., Mori, M. & Garzotto, M., Sep 1 2005, In : BJU international. 96, 4, p. 503-507 5 p.

Research output: Contribution to journalArticle

40 Scopus citations

High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: A phase I/II study

Tiffany, N. M., Ryan, C. W., Garzotto, M., Wersinger, E. M. & Beer, T. M., Sep 2005, In : Journal of Urology. 174, 3, p. 888-892 5 p.

Research output: Contribution to journalArticle

40 Scopus citations